Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · April 02, 2024

SGLT2 Inhibitors vs GLP-1 Receptor Agonists and Clinical Outcomes in Patients With Diabetes With or Without Atrial Fibrillation

The Journal of Clinical Endocrinology and Metabolism


Additional Info

Disclosure statements are available on the authors' profiles:

The Journal of Clinical Endocrinology and Metabolism
SGLT2 inhibitors vs. GLP-1 receptor agonists and clinical outcomes in patients with diabetes with/without atrial fibrillation
J. Clin. Endocrinol. Metab. 2024 Mar 11;[EPub Ahead of Print], YH Chan, TF Chao, SW Chen, HF Lee, PR Li, YH Yeh, CT Kuo, LC See, GYH Lip

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading